NVS NOVELSTAR PHARMACEUTICALS INC. Trademark

Trademark Overview

On Wednesday, June 27, 2018, a trademark application was filed for NVS NOVELSTAR PHARMACEUTICALS INC. with the United States Patent and Trademark Office. The USPTO has given the NVS NOVELSTAR PHARMACEUTICALS INC. trademark a serial number of 88016708. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 19, 2022. This trademark is owned by Novelstar Pharmaceuticals Inc.. The NVS NOVELSTAR PHARMACEUTICALS INC. trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in treatment of human diseases and disorders, namely, skin disorders, eye disorders, cardiovascular diseases, diseases of the digestive systems, diseases of the blood system, neurological diseases, musculoskeletal diseases, infectious diseases, urological diseases, immunological diseases, allergies, wounds, hypertension, cancer, pain, diabetes
nvs novelstar pharmaceuticals inc.

General Information

Serial Number88016708
Word MarkNVS NOVELSTAR PHARMACEUTICALS INC.
Filing DateWednesday, June 27, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 19, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 18, 2019

Trademark Statements

Description of MarkThe mark consists of a circle with enclosed stylized text of "NVS", followed by text which reads "Novelstar", under which is set forth a text "Pharmaceuticals Inc.".
Goods and ServicesPharmaceutical preparations for use in treatment of human diseases and disorders, namely, skin disorders, eye disorders, cardiovascular diseases, diseases of the digestive systems, diseases of the blood system, neurological diseases, musculoskeletal diseases, infectious diseases, urological diseases, immunological diseases, allergies, wounds, hypertension, cancer, pain, diabetes
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS INC."

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, July 1, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovelstar Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512
Party NameNovelstar Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events

Event DateEvent Description
Monday, September 19, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 19, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 16, 2022SOU EXTENSION 5 GRANTED
Monday, February 14, 2022SOU EXTENSION 5 FILED
Monday, February 14, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 13, 2021SOU EXTENSION 4 GRANTED
Friday, August 13, 2021SOU EXTENSION 4 FILED
Friday, August 13, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 12, 2021SOU EXTENSION 3 GRANTED
Friday, February 12, 2021SOU EXTENSION 3 FILED
Friday, February 12, 2021SOU TEAS EXTENSION RECEIVED
Friday, August 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 12, 2020SOU EXTENSION 2 GRANTED
Wednesday, August 12, 2020SOU EXTENSION 2 FILED
Wednesday, August 12, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, March 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 18, 2020CORRECTED NOA E-MAILED
Tuesday, March 17, 2020SOU EXTENSION 1 GRANTED
Thursday, February 13, 2020SOU EXTENSION 1 FILED
Tuesday, March 17, 2020DIVISIONAL PROCESSING COMPLETE
Thursday, February 13, 2020DIVISIONAL REQUEST RECEIVED
Tuesday, March 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 13, 2020TEAS REQUEST TO DIVIDE RECEIVED
Thursday, February 13, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, August 13, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 16, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 16, 2019ASSIGNED TO LIE
Wednesday, May 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, April 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, April 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 1, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 1, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 11, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 11, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 23, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 23, 2018NON-FINAL ACTION E-MAILED
Tuesday, October 23, 2018NON-FINAL ACTION WRITTEN
Thursday, October 18, 2018ASSIGNED TO EXAMINER
Tuesday, July 3, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, July 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 30, 2018NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals novelstar diseases disorders immunological urological musculoskeletal infectious allergies hypertension diabetes pain